Status:
COMPLETED
Development of Positive Psychotherapy for Smoking Cessation
Lead Sponsor:
Brown University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical t...
Eligibility Criteria
Inclusion
- smoke at least 5 cigarettes per day for longer than one year with no other ongoing tobacco product use
- willing to use the transdermal nicotine patch
- report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking.
Exclusion
- are currently experiencing psychotic symptoms, affective disorder (major depression, dysthymia, or mania) or substance use disorder (other than nicotine dependence)
- taking prescribed psychotropic medication or receiving other forms of psychotherapy
- concomitantly using other pharmacotherapies for smoking cessation
- have any contraindications for use of the transdermal nicotine patch.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01451814
Start Date
October 1 2011
End Date
February 1 2014
Last Update
March 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Alcohol and Addiction Studies, Brown University
Providence, Rhode Island, United States, 02912